|
1
|
Deans RJ and Moseley AB: Mesenchymal stem
cells: biology and potential clinical uses. Exp Hematol.
28:875–884. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bianco P and Gehron Robey P: Marrow
stromal stem cells. J Clin Invest. 105:1663–1668. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Barry FP and Murphy JM: Mesenchymal stem
cells: clinical applications and biological characterization. Int J
Biochem Cell Biol. 36:568–584. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bianco P, Robey PG and Simmons PJ:
Mesenchymal stem cells: revisiting history, concepts, and assays.
Cell Stem Cell. 2:313–319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Anjos-Afonso F and Bonnet D:
Nonhematopoietic/endothelial SSEA-1+ cells define the most
primitive progenitors in the adult murine bone marrow mesenchymal
compartment. Blood. 109:1298–1306. 2007.PubMed/NCBI
|
|
7
|
In 't Anker PS, Scherjon SA, Kleijburg-van
der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE and Kanhai HH:
Isolation of mesenchymal stem cells of fetal or maternal origin
from human placenta. Stem Cells. 22:1338–1345. 2004.
|
|
8
|
Zuk PA, Zhu M, Mizuno H, Huang J, Futrell
JW, Katz AJ, Benhaim P, Lorenz HP and Hedrick MH: Multilineage
cells from human adipose tissue: implications for cell-based
therapies. Tissue Eng. 7:211–228. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sato K, Ozaki K, Oh I, Meguro A, Hatanaka
K, Nagai T, Muroi K and Ozawa K: Nitric oxide plays a critical role
in suppression of T-cell proliferation by mesenchymal stem cells.
Blood. 109:228–234. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rasmusson I, Ringdén O, Sundberg B and Le
Blanc K: Mesenchymal stem cells inhibit lymphocyte proliferation by
mitogens and alloantigens by different mechanisms. Exp Cell Res.
305:33–41. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Krampera M, Glennie S, Dyson J, Scott D,
Laylor R, Simpson E and Dazzi F: Bone marrow mesenchymal stem cells
inhibit the response of naive and memory antigen-specific T cells
to their cognate peptide. Blood. 101:3722–3729. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Di Nicola M, Carlo-Stella C, Magni M,
Milanesi M, Longoni PD, Matteucci P, Grisanti S and Gianni AM:
Human bone marrow stromal cells suppress T-lymphocyte proliferation
induced by cellular or nonspecific mitogenic stimuli. Blood.
99:3838–3843. 2002.
|
|
13
|
Koç ON, Day J, Nieder M, Gerson SL,
Lazarus HM and Krivit W: Allogeneic mesenchymal stem cell infusion
for treatment of metachromatic leukodystrophy (MLD) and Hurler
syndrome (MPS-IH). Bone Marrow Transplant. 30:215–222.
2002.PubMed/NCBI
|
|
14
|
Djouad F, Fritz V, Apparailly F,
Louis-Plence P, Bony C, Sany J, Jorgensen C and Noël D: Reversal of
the immunosuppressive properties of mesenchymal stem cells by tumor
necrosis factor alpha in collagen-induced arthritis. Arthritis
Rheum. 52:1595–1603. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zappia E, Casazza S, Pedemonte E,
Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti
F, Frassoni F, et al: Mesenchymal stem cells ameliorate
experimental autoimmune encephalomyelitis inducing T-cell anergy.
Blood. 106:1755–1761. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nakamizo A, Marini F, Amano T, Khan A,
Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, et
al: Human bone marrow-derived mesenchymal stem cells in the
treatment of gliomas. Cancer Res. 65:3307–3318. 2005.PubMed/NCBI
|
|
17
|
Hall BM, Fortney JE, Taylor L, Wood H,
Wang L, Adams S, Davis S and Gibson LF: Stromal cells expressing
elevated VCAM-1 enhance survival of B lineage tumor cells. Cancer
Lett. 207:229–239. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Djouad F, Plence P, Bony C, Tropel P,
Apparailly F, Sany J, Noël D and Jorgensen C: Immunosuppressive
effect of mesenchymal stem cells favors tumor growth in allogeneic
animals. Blood. 102:3837–3844. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Khakoo AY, Pati S, Anderson SA, Reid W,
Elshal MF, Rovira II, Nguyen AT, Malide D, Combs CA, Hall G, et al:
Human mesenchymal stem cells exert potent antitumorigenic effects
in a model of Kaposi's sarcoma. J Exp Med. 203:1235–1247. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu W, Zhang X, Qian H, Zhu W, Sun X, Hu J,
Zhou H and Chen Y: Mesenchymal stem cells from adult human bone
marrow differentiate into a cardiomyocyte phenotype in vitro. Exp
Biol Med (Maywood). 229:623–631. 2004.PubMed/NCBI
|
|
21
|
D'Agostino B, Sullo N, Siniscalco D, De
Angelis A and Rossi F: Mesenchymal stem cell therapy for the
treatment of chronic obstructive pulmonary disease. Expert Opin
Biol Ther. 10:681–687. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mazzini L, Ferrero I, Luparello V,
Rustichelli D, Gunetti M, Mareschi K, Testa L, Stecco A, Tarletti
R, Miglioretti M, et al: Mesenchymal stem cell transplantation in
amyotrophic lateral sclerosis: a phase I clinical trial. Exp
Neurol. 223:229–237. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Loebinger MR, Eddaoudi A, Davies D and
Janes SM: Mesenchymal stem cell delivery of TRAIL can eliminate
metastatic cancer. Cancer Res. 69:4134–4142. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Han ZP, Zhang SS, Jing YY, Bu XX,
Wang CY, Sun K, Jiang GC, Zhao X, Li R, et al: Effects of
inflammatory factors on mesenchymal stem cells and their role in
the promotion of tumor angiogenesis in colon cancer. J Biol Chem.
286:25007–25015. 2011. View Article : Google Scholar : PubMed/NCBI
|
